A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models (Q46162383)
Jump to navigation
Jump to search
scientific article published in September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models |
scientific article published in September 2004 |
Statements
1 reference
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models (English)
1 reference
1 reference
Stuart Emanuel
1 reference
Robert H Gruninger
1 reference
Angel Fuentes-Pesquera
1 reference
Peter J Connolly
1 reference
Jennifer A Seamon
1 reference
Rose Tominovich
1 reference
Beth Hollister
1 reference
Cheryl Napier
1 reference
Michael R D'Andrea
1 reference
Michael Reuman
1 reference
Gilles Bignan
1 reference
Robert Tuman
1 reference
Dana Johnson
1 reference
David Moffatt
1 reference
Mark Batchelor
1 reference
Anne Foley
1 reference
James O'Connell
1 reference
Rodger Allen
1 reference
Martin Perry
1 reference
Linda Jolliffe
1 reference
Steven A Middleton
1 reference
1 September 2004
1 reference
66
1 reference
3
1 reference
635-647
1 reference
Identifiers
1 reference